Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

JCOG0603: Are We Really Sure This Was a Negative Trial?

Auteurs : Saude Conde R, Bregni G, Saad E, Hendlisz A, Sclafani F
Jaar : 2022
Journal : J Clin Oncol
Pagina's : JCO2102299

Deep Epigastric Lymph Nodes Implication in Patients' Recurrence Pattern After Cytoreductive Surgery in Colorectal Peritoneal Metastases.

Auteurs : El Asmar A, Vouche M, Galdon MG, Bali MA, Sclafani F, Donckier V, Liberale G
Jaar : 2022
Journal : J Gastrointest Surg

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.

Auteurs : Koessler T, Alsina M, Arnold D, Ben-Aharon I, Collienne M, Lutz MP, Neuzillet C, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M
Jaar : 2022
Journal : ESMO Open
Volume : 7
Pagina's : 100392

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Auteurs : Wrona E, Potemski P, Sclafani F, Borowiec M
Jaar : 2021
Journal : Arch Immunol Ther Exp (Warsz)
Volume : 69
Pagina's : 2

Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

Auteurs : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F
Jaar : 2021
Journal : Acta oncol (Stockholm)
Volume : 60
Pagina's : 549-553

Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials.

Auteurs : Giunta EF, Bregni G, Hendlisz A, Sclafani F
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 372-377

Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.

Auteurs : Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali MA, Moretti L, Troiani T, Ciardiello F, Hendlisz A, Sclafani F
Jaar : 2021
Journal : Cancer Treat Rev
Volume : 96
Pagina's : 102177

Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer.

Auteurs : Sclafani F, Corrò C, Koessler T
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?

Auteurs : Hendlisz A, Sclafani F
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 351-352

Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Auteurs : Deleporte A, Van den Eynde M, Forget F, Holbrechts S, Delaunoit T, Houbiers G, Kalantari HR, Laurent S, Vanderstraeten E, De Man M, Vergauwe P, Clausse M, Van Der Auwera J, DHondt L, Pierre P, Ghillemijn B, Covas A, Paesmans M, Ameye L, Awada A, Sclafani F, Hendlisz A
Jaar : 2021
Journal : Cancer Med
Volume : 10
Pagina's : 4366-4374

Targeted agents in older patients with gastrointestinal cancers - An overview.

Auteurs : Monteiro AR, Conde RS, Basto R, Sclafani F, Deleporte A, Hendlisz A, Dal Lago L
Jaar : 2021
Journal : J Geriatr Oncol
Volume : 12
Pagina's : 1240-1252

Buschke-Löwenstein tumor in a human immunodeficiency virus-positive patient: a case report and short literature review.

Auteurs : Ledouble V, Sclafani F, Hendlisz A, Gomez Galdon M, Liberale G
Jaar : 2021
Journal : Acta Gastroenterol Belg
Volume : 84
Pagina's : 343-345

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.

Auteurs : Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P
Jaar : 2021
Journal : Cancer Treat Rev
Pagina's : 102208

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Auteurs : Woff E, Salvatore L, Marmorino F, Genovesi D, Critchi G, Guiot T, Ameye L, Sclafani F, Hendlisz A, Flamen P
Jaar : 2021
Journal : J Nucl Med

Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.

Auteurs : Vandeputte C, Bregni G, Gkolfakis P, Guiot T, Pretta A, Kehagias P, Senti C, Reina EA, Van Bogaert C, Deleporte A, Geboes K, Delaunoit T, Demolin G, Peeters M, DHondt L, Janssens J, Carrasco J, Holbrechts S, Goeminne JC, Vergauwe P, Van Laethem JL, Flamen P, Hendlisz A, Sclafani F
Jaar : 2021
Journal : Clin Colorectal Cancer

Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives.

Auteurs : Personeni N, Smiroldo V, Giunta EF, Prete MG, Rimassa L, Bregni G, Sclafani F
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Fat density is a novel prognostic marker in patients with esophageal cancer.

Auteurs : Anciaux M, Van Gossum A, Wenglinski C, Ameye L, Guiot T, Flamen P, Demetter P, Deleporte A, Sclafani F, Donckier V, Hendlisz A, Vandeputte C
Jaar : 2020
Journal : Clin Nutr ESPEN
Volume : 39
Pagina's : 124-130

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18 F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.

Auteurs : Camera S, Akin Telli T, Woff E, Vandeputte C, Kehagias P, Guiot T, Critchi G, Wissam Y, Bregni G, Trevisi E, Pretta A, Senti C, Leduc S, Gkolfakis P, Hoerner F, Rothé F, Sclafani F, Flamen P, Deleporte A, Hendlisz A
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial.

Auteurs : Fontana E, Nyamundanda G, Cunningham D, Tu D, Cheang MCU, Jonker DJ, Siu LL, Sclafani F, Eason K, Ragulan C, Bali MA, Hulkki-Wilson S, Loree JM, Waring PM, Giordano M, Lawrence P, Rodrigues DN, Begum R, Shapiro JD, Price TJ, Cremolini C, Starling N, Pietrantonio F, Trusolino L, OCallaghan CJ, Sadanandam A
Jaar : 2020
Journal : JCO Precis Oncol
Volume : 4

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016.

Auteurs : Ladanie A, Schmitt AM, Speich B, Naudet F, Agarwal A, Pereira TV, Sclafani F, Herbrand AK, Briel M, Martin-Liberal J, Schmid T, Ewald H, Ioannidis JPA, Bucher HC, Kasenda B, Hemkens LG
Jaar : 2020
Journal : JAMA Netw Open
Volume : 3
Pagina's : e2024406